Benjamin P. Levy, MD; Andrew Lerner, MD; and Andrea Richardson, MD, PhD, describe the multidisciplinary tumor board as a forum for communication among the members of the care team for a patient with non–small cell lung cancer, as well as the challenges associated with various diagnostic techniques.